Phosphoproteomics × Rapid DIA Promotion

Dual-Omics Phosphoproteomics on Orbitrap Astral — Rapid DIA Quantitative Proteomics Included

Both datasets acquired via DIA on Orbitrap Astral. Deeper phosphosite coverage. Sharper quantification. A more complete picture of your signaling biology — from a single submission.

Promotion Details

Offer: Rapid DIA quantitative proteomics included with every phosphoproteomics submission (same sample)

Quote Period: Sep 1 – Oct 31, 2026

Promotion Code: Phospho_RapidDIA

The Phosphoproteomics Blind Spot

Phosphoproteomics tells you what's phosphorylated — but not whether it's true signaling or just a shift in protein abundance. Without matched proteomics:

False positives — abundance shifts mimic phosphorylation changes
Gaps in your story — top journals increasingly demand dual-omics validation
Misallocated effort — follow-ups chase expression noise, not real regulatory rewiring

Corrected phosphosite fold‑change = phosphosite FC / parent‑protein abundance FC

Normalize phosphorylation changes against protein expression to strip out false positives and isolate the regulatory events that matter.

DIA on Orbitrap Astral — Across Both Datasets

Orbitrap Astral platform advantages:

Speed — High-speed MS/MS for deep phosphoproteome coverage, including low-abundance regulatory sites.
Sensitivity — Advanced ion optics detect low-copy modifications at physiological levels.
Dynamic range — Reliable quantification across orders of magnitude in complex matrices.

Fig1. Thermo Fisher Orbitrap Astral at Novogene US Laboratory

One Submission. Two DIA Datasets

Phosphoproteomics (DIA on Astral):

Sample preparation → TiO₂/IMAC enrichment → DIA-based LC-MS/MS → Unified report

(Phosphosite identification, localization, kinase–substrate predictions, etc.)

Fig2. From sample intake to integrated phosphoproteomic insights — a fully managed, turnkey workflow

Rapid DIA Quantitative Proteomics — Included at No Charge (DIA on Astral):

Ultra-fast DIA acquisition → 180 samples/day → Protein-level quantification matrix → Unified report

Integrated Dual-Omics Analysis:

Multi-dimensional database cross-matching → Phosphorylation normalization → Unified report

(differential expression, Kinase activity inference, functional analysis, etc.)

Terms and Conditions

Offer valid on quotes issued Sep 1 – Oct 31, 2026.
PO or payment must be received by Nov 15, 2026; all samples by Dec 2, 2026.
For Research Use Only. Exclusive to customers in North and South America.
Novogene reserves the right to modify or withdraw this offer at any time.

Let’s Talk about Your NGS Project

(Fields marked with an * are required)

First Name*

Last Name*

Email Address*

Institution/Organization*

Country/Region*

State*

Tell us more about your project or service of interest.*

Novogene Corporation Inc.

2921 Stockton Blvd. Suite 1810, Sacramento CA 95817

916-252-0068 inquiry@novogeneusa.com www.novogeneusa.com